Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Receives Consensus Rating of “Hold” from Brokerages
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Get Free Report) has earned an average recommendation of “Hold” from the five analysts that are currently covering the company, MarketBeat Ratings reports. Three research analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 12-month price target among […]
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Get Free Report) has earned an average recommendation of “Hold” from the five analysts that are currently covering the company, MarketBeat Ratings reports. Three research analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 12-month price target among […]
